PHT Corporation President and CEO Philip Lee Named to Prestigious PharmaVOICE 100 Most Influential People in Life Sciences

Head of global ePRO market and technology leader praised for his intrinsic understanding of the pharma industry, and amazing ability to foresee and address its needs

BOSTON & GENEVA--(BUSINESS WIRE)-- PHT Corporation announced that President and CEO Philip Lee is one of PharmaVOICE magazine’s 100 most inspiring people in life sciences. PHT is the global innovator in ePRO solutions that maximize the collection of high quality data from clinical trial patients.

Philip Lee, President & CEO, PHT Corporation (Photo: Business Wire)

Philip Lee, President & CEO, PHT Corporation (Photo: Business Wire)

Phil Lee was recognized for his achievements in driving eClinical research forward with innovative ePRO Systems. He is acknowledged worldwide for leading PHT to dominance in the industry as the largest ePRO System provider to the world’s largest and most innovative pharmaceutical companies.

Established seven years ago by PharmaVOICE magazine, the PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life-sciences industry. Taren Grom, editor-in-chief and cofounder of PharmaVOICE, said, “The PharmaVOICE 100 are individuals who think outside the box, pioneer new paths to success, and inspire their colleagues in the industry; they translate industry issues into opportunities and take the time to mentor the next generation of leaders in the life-sciences arena. We are extremely pleased to recognize these 100 individuals in the July-August issue.”

Phil Lee, said, “My goal is to promote the proven safety, science and economic benefits of ePRO Systems in clinical trials. I’m very honored to be recognized by PharmaVOICE and by my peers and colleagues in the industry.”

Mr. Lee brought a sophisticated background of achievement in both business and science to PHT. He has more than 30 years of experience in the software industry with 15 years devoted to serving the clinical research community.

Prior to PHT he served as President and CEO of Clinsoft (formerly known as Domain Pharma Corporation) where he helped the company achieve market dominance in clinical data management systems and adverse event reporting systems. Under Mr. Lee's leadership, the company doubled its revenues, achieved profitability and launched its electronic data capture (EDC) solution to the market. Mr. Lee was also President of eXcelon Corporation (EXLN), one of the leaders in the XML database market and the Object Oriented Database market. He has also held senior level positions at Oracle Corporation, Interleaf Inc. and BBN Software Products (Bolt Beranek and Newman). He holds a Bachelor of Science and a Masters of Engineering Degree in Operations Research/Industrial Engineering from Cornell University.

About PHT Corporation

PHT Corporation is the industry's only dedicated full-service ePRO provider. PHT offers clients a comprehensive solution for acquiring, managing and analyzing data collected directly from patients through all phases of clinical development. More than 115 biopharmaceutical companies use PHT's ePRO System to easily collect high quality, regulatory compliant clinical trial data. PHT's proven LogPad®, NetPRO and versatile SitePad® Systems deliver the voice of the patient, in 88 languages, from homes and sites in 67 countries around the world. Patient experiences captured firsthand by PHT's ePRO System have been used successfully in at least 18 regulatory submissions and 16 approvals to date resulting in 14 PRO-based label claims for sponsors. For more information on PRO and ePRO innovations, review the interactive content and demonstrations at the award-winning

PHT, LogPad, NetPRO and SitePad are registered trademarks of PHT Corporation.

Photos/Multimedia Gallery Available:


PHT Corporation
Brenda Nashawaty, 617-688-3253
[email protected]

KEYWORDS:   United States  Europe  North America  Massachusetts  Switzerland

INDUSTRY KEYWORDS:   Technology  Data Management  Internet  Software  Health  Biotechnology  Clinical Trials  Hospitals  Pharmaceutical


Philip Lee, President & CEO, PHT Corporation (Photo: Business Wire)